AXL-IN-13

AXL-IN-13 is a potent and orally active AXL inhibitor with an IC50 of 1.6 nM and a Kd of 0.26 nM. It exhibits anticancer activity, reverses TGF-β1-induced epithelial-mesenchymal transition (EMT), and inhibits cancer cell migration and invasion.

Product Specifications

CAS Number

2376928-82-2

Stability

≥ 2 years

Purity

>98% (HPLC)

Weight

632.72

Molecular Formula

C34H41FN6O5

Notes

Research use only, not for human use.

Receptor

FLT | PDGFR | TGF-beta/Smad | TAM Receptor

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

RC212915L4V 200 µL

PSIP1 (NM_021144) Human Tagged ORF Clone Lentiviral Particle

Ask

View Details

TA314477 100 µL

RPS4Y1 Rabbit Polyclonal Antibody

Ask

View Details

51489161 1.0 µg

ZNF385D AAV siRNA Pooled Vector

Ask

View Details

RC208112L2 10 µg

MBNL1 (NM_021038) Human Tagged Lenti ORF Clone

Ask

View Details

E-AB-F10210-01 25 µg

AF/LE Purified Anti-Mouse CD22 Antibody[Cy34.1]

Ask

View Details

E-AB-F10210-02 100 µg

AF/LE Purified Anti-Mouse CD22 Antibody[Cy34.1]

Ask

View Details